A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler

Clinical trial NCT01371786 · COMPLETED

Trial details

NCT number: NCT01371786
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Allergic Rhinitis (AR)

Start date: 2011-06-01
Primary completion: 2011-08-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.